Life Science Leader Magazine Supplements

CRO Guide 2016

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/672523

Contents of this Issue

Navigation

Page 27 of 45

LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2016 26 CROs OUTSOURCING have an agreement. CRO performance ratings and an understanding of CRO selection criteria are essential tools in an organization's choice of service providers. Decision- makers at sponsor companies can use the experiences and insights of their peers as a lens through which to examine and enhance their own approaches to clinical outsourcing. For CROs, knowing where their business exceeds expecta- tions and where it falls short will aid in marketing their abilities and improving potential shortcomings. L experience with similar study types and for strong patient recruitment strategy . Desiring experience with similar study types is logical, since the providers have not already been through a preferred provider vetting process to ensure that they have sufficient experience. Low cost also comes into play when choosing a provider not on the company's preferred list. As preferred provider agreements often include pre- negotiated rates, decision-makers may be more price-sensitive when choosing a provider with which they do not already preferred list, and selecting a provider when a preferred list does not exist may lead to different priorities and inter- ests taking precedence in the decision. To investigate this further, ISR asked respondents with Phase 2/3 decision- making responsibilities about selection criteria when choosing providers in each of the aforementioned selection environments. Figure 1 displays the five most important attributes in each of the decision-making scenarios and illustrates how each scenario can allow selection attributes to become more or less relevant. Operational excellence and therapeu- tic expertise rank among the top-five most important selection drivers in each decision-making environment. In fact, operational excellence is the #1 most important attribute in each of the envi- ronments. Not surprisingly, these areas are critical for selection regardless of how a provider is chosen. Now to examine the nuances of each of the scenarios: When choosing among preferred providers, project manager quality and global footprint are among the top-five most important attributes, but this is not the case for the other scenarios. A decision-making scenario could easily be imagined where stake- holders know that the providers have the necessary operational and therapeutic experience (due to the vetting process they underwent to be included on the preferred list) and now need to further narrow the list of potential providers based on whether the project managers are of sufficient caliber and whether the geographic scope can be managed successfully. Choosing a provider that is not on the company's preferred list and choosing a provider in absence of a preferred list yield similar results in terms of the most important attributes. Decision- makers are looking for providers to have Survey Methodology: Industry Standard Research is a full-service market research provider to the pharma and pharma services industries. ISR's CRO quality benchmarking research is conducted annually via an online survey. For the 2016 CRO Awards data, more than 60 service providers were evaluated on over 25 different performance metrics. Research participants were recruited from biopharmaceutical companies of all sizes and screened for decision-making infuence and authority when it comes to working with CROs. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months. This level of qualifcation ensures that quality ratings come from actual involvement with a business and that companies identifed as leaders are backed by experiential data. For more information, please visit www.ISRreports.com. By R. McAvoy USE PEERS' EXPERIENCES TO MAKE EDUCATED CRO SELECTIONS C H O O S I N G A M O N G P R E F E R R E D P R O V I D E R S C H O O S I N G O F F P R E F E R R E D P R O V I D E R L I S T LOW COST PROJECT MANAGER QUALITY GLOBAL FOOTPRINT OPERATIONAL EXCELLENCE THERAPEUTIC EXPERTISE EXPERIENCE WITH SIMILAR STUDY TYPES PATIENT RECRUITMENT STRATEGY PRIOR POSITIVE EXPERIENCE WITH SERVICE PROVIDER C H O O S I N G W I T H N O P R E F E R R E D P R O V I D E R L I S T © Industry Standard Research Figure 1

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Guide 2016